These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17540007)

  • 1. Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line.
    Bosier B; Tilleux S; Najimi M; Lambert DM; Hermans E
    J Neurochem; 2007 Sep; 102(6):1996-2007. PubMed ID: 17540007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression.
    Bosier B; Hermans E; Lambert DM
    Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.
    Bosier B; Muccioli GG; Mertens B; Sarre S; Michotte Y; Lambert DM; Hermans E
    Neuropharmacology; 2012 Jun; 62(7):2328-36. PubMed ID: 22365976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B; Muccioli GG; Lambert DM
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells.
    Bosier B; Lambert DM; Hermans E
    FEBS Lett; 2008 Nov; 582(28):3861-7. PubMed ID: 18950629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of AP-1- and CRE-driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor.
    Bosier B; Hermans E; Lambert D
    Br J Pharmacol; 2008 Sep; 155(1):24-33. PubMed ID: 18536748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme.
    Hernández M; Berrendero F; Suárez I; García-Gil L; Cebeira M; Mackie K; Ramos JA; Fernández-Ruiz J
    Brain Res; 2000 Feb; 857(1-2):56-65. PubMed ID: 10700552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.
    García C; Palomo-Garo C; García-Arencibia M; Ramos J; Pertwee R; Fernández-Ruiz J
    Br J Pharmacol; 2011 Aug; 163(7):1495-506. PubMed ID: 21323909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells.
    Zhou D; Song ZH
    J Neurosci Res; 2001 Aug; 65(4):346-53. PubMed ID: 11494371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors.
    Redmond WJ; Cawston EE; Grimsey NL; Stuart J; Edington AR; Glass M; Connor M
    Br J Pharmacol; 2016 Jan; 173(1):115-27. PubMed ID: 26398720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling.
    Molina-Holgado F; Pinteaux E; Heenan L; Moore JD; Rothwell NJ; Gibson RM
    Mol Cell Neurosci; 2005 Jan; 28(1):189-94. PubMed ID: 15607953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
    Govaerts SJ; Hermans E; Lambert DM
    Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.
    Fan Y; Hooker BA; Garrison TR; El-Kouhen OF; Idler KB; Holley-Shanks RR; Meyer MD; Yao BB
    Eur J Pharmacol; 2011 Jun; 659(2-3):161-8. PubMed ID: 21458448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.
    Daigle TL; Kearn CS; Mackie K
    Neuropharmacology; 2008 Jan; 54(1):36-44. PubMed ID: 17681354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland.
    González S; Manzanares J; Berrendero F; Wenger T; Corchero J; Bisogno T; Romero J; Fuentes JA; Di Marzo V; Ramos JA; Fernández-Ruiz J
    Neuroendocrinology; 1999 Aug; 70(2):137-45. PubMed ID: 10461028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
    Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA
    Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
    Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
    Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates.
    Gonsiorek W; Lunn CA; Fan X; Deno G; Kozlowski J; Hipkin RW
    Br J Pharmacol; 2007 Aug; 151(8):1262-71. PubMed ID: 17603556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones.
    Straiker A; Wager-Miller J; Hutchens J; Mackie K
    Br J Pharmacol; 2012 Apr; 165(8):2660-71. PubMed ID: 22014238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.